Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease

Title: Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease
Authors: Wu, Wenhao; Hou, Zebin
Source: Frontiers in Immunology ; volume 16 ; ISSN 1664-3224
Publisher Information: Frontiers Media SA
Publication Year: 2025
Collection: Frontiers (Publisher - via CrossRef)
Description: Background Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated metabolic dysfunction-associated liver disease (MetALD) are significant public health concerns, with diet playing a pivotal role in their pathogenesis. Aims: Using data from the National Health and Nutrition Examination Survey (NHANES) 2007–2018. This study investigates the associations of the dietary index for gut microbiota (DI-GM), dietary inflammatory index (DII), and their combined effects with MASLD/MetALD, while exploring the mediating roles of inflammation and metabolic dysfunction. Methods Data from the 2007 to 2018 NHANES included 9,529 participants. DI-GM and DII were calculated using 24-hour dietary recalls. Inflammatory and metabolic biomarkers—including triglyceride-glucose (TyG) index, metabolic score (MS), C-reactive protein (CRP), systemic immune inflammation index (SII), and systemic inflammatory response index (SIRI)—were analyzed. Multivariable logistic and linear regression, subgroup analyses, and restricted cubic spline (RCS) models assessed associations and dose-response relationships. Mediation analysis evaluated the roles of inflammatory and metabolic markers. Results Higher DI-GM scores were significantly associated with reduced MASLD (OR = 0.59, 95% CI: 0.46–0.75) and MetALD (OR = 0.57, 95% CI: 0.46–0.70). Conversely, higher DII scores were positively associated with MASLD (OR = 1.57, 95% CI: 1.23–2.01) and MetALD (OR = 1.40, 95% CI: 1.13–1.75). DI-GM was inversely associated with inflammation and metabolic markers (TyG: β= -0.05, MS: β= -0.11, CRP: β= -0.12, SII: β= -0.08, SIRI: β= -0.09), while DII exacerbated these markers (TyG: β= 0.06, MS: β= 0.18, CRP: β=0.14, SII: β= 0.11, SIRI: β= 0.10). The combined effects of DI-GM and DII further demonstrated that a gut microbiota-healthy and anti-inflammatory diet synergistically reduced MASLD (OR = 0.59, 95% CI: 0.43–0.81) and MetALD risks (OR = 0.58, 95% CI: 0.44–0.76). Mediation analysis confirmed that inflammation and metabolism ...
Document Type: article in journal/newspaper
Language: unknown
DOI: 10.3389/fimmu.2025.1593245
DOI: 10.3389/fimmu.2025.1593245/full
Availability: https://doi.org/10.3389/fimmu.2025.1593245; https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593245/full
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.186F09C7
Database: BASE